Thrombosis Research

Article	Citations
Major in-hospital bleeding in patients with pulmonary embolism treated with systemic thrombolysis	72
A novel role of acellular hemoglobin in hemolytic thrombosis	67
PO-08: Characterisation of plasma extracellular vesicles in myeloproliferative neoplasms	60
PO-51: Kaposiform hemangioendothelioma is associated with platelet functional abnormalities that persist in patients even after complete blood cell count recovery	54
PO-39: Superior vena cava stenting: an effective and safe therapeutic choice for the treatment of superior vena cava syndrome in lung cancer patients	52
Pre-admission anticoagulant therapy and mortality in hospitalized COVID-19 patients: A retrospective cohort study	51
DOACs: A perfect fit for patients with bariatric surgery?	45
Quality and predictors of oral anticoagulation therapy with vitamin K antagonists in adult congenital heart disease: TTR and INR variability	39
Decreased patency of transjugular intrahepatic portosystemic shunts performed for splanchnic vein thrombosis in patients with myeloproliferative neoplasms	39
Is all collagen the same for platelet testing? Editorial on “Platelet collagen receptors and their role in modulating platelet adhesion patterns and activation on alternatively processed collagen subs	38
Corrigendum to “Repurposing of rilpivirine for preventing platelet β3 integrin-dependent thrombosis by targeting c-Src active autophosphorylation” [Thromb. Res. 229 (2023) 53–68]	37
Pulmonary embolism: Age specific temporal trends in incidence and mortality in Denmark 1999–2018	36
Investigation of the impact of antithrombin deficiency on the inflammatory response: Results from a single centre cohort study	36
Validation of the Academic Research Consortium for High Bleeding Risk criteria in Chinese patients with atrial fibrillation and acute coronary syndrome or undergoing percutaneous coronary intervention	36
Crosstalk between hemostasis and immunity in cancer pathogenesis	36
Editorial Board	34
Acute and subacute effects of strenuous exercise on platelet aggregation, coagulation and fibrinolysis in patients with stable coronary artery disease	33
Clinical outcomes of cancer-associated isolated superficial vein thrombosis in daily practice	32
Direct oral anticoagulants or low-molecular-weight heparins for venous thromboembolism in patients with brain tumors	32
Vaccine-induced immune thrombocytopenia and thrombosis after mRNA-1273 booster vaccination	30
Cost of immune tolerance induction according to its outcome in people with hemophilia A and inhibitors: results from the Co$tIT study	30
Unveiling the predictive capacity of inflammatory and platelet markers for central retinal artery occlusion	29
Rivaroxaban plus aspirin versus acenocoumarol to manage recurrent venous thromboembolic events despite systemic anticoagulation with rivaroxaban	29
Clonal hematopoiesis and cardiovascular disease in cancer patients and survivors	27
The role of interleukin-10 gene variants in inhibitor development in hemophilia: A meta-analysis	26

Regulation of fibrinogen synthesis	26
Cyclophosphamide vs rituximab for eradicating inhibitors in acquired hemophilia A: A randomized trial in 108 patients	26
PO-22: Rate of venous thromboembolism events in cancer patients treated by radiation therapy: the Radiation-Induced Thrombosis study	25
Predicting post-discharge venous thromboembolism and bleeding among medical patients: External validation of a novel risk score utilizing ubiquitous biomarkers	25
PO-40: Therapeutic approaches of superior vena cava syndrome in patients with non-small cell lung cancer (NSCLC)	25
PO-56: Low molecular weight heparin beyond 12 months in patients with cancer associated thrombosis: CAT-LONG study	25
PO-18: Myocardial infarction and risk of cancer	25
Preface to the Proceedings of the 11th International Conference on Thrombosis and Hemostasis Issues in Cancer, 2022	24
PO-60: Comparison of inferior vena cava (IVC) filter use and outcomes between cancer and non-cancer patients in a single-center cohort	24
Safety of fixed-dose heparin titration boluses in underweight patients	23
Predicting functional outcomes after acute ischemic stroke – Is thrombelastography useful outside perioperative bleeding management?	23
In vitro procoagulant effects of Gla-domainless factor Xa in factor XI-deficient and factor IX-deficient plasma	23
Intrinsic coagulant potential modulates anticoagulant efficacy of rivaroxaban	22
Main features of ischemic stroke in patients with acute immune-mediated thrombotic thrombocytopenic purpura	22
Large deletions and small insertions and deletions in the factor VIII gene predict unfavorable immune tolerance induction outcome in people with severe hemophilia A and high-responding inhibitors	22
Vaccine-induced immune thrombotic thrombocytopenia and patients with cancer	22
Letter to the editors-in-chief reply to: Solinas et al. Venous and arterial thromboembolic events with immune check point inhibitors: A systematic review	22
Pulmonary embolism bleeding score index (PEBSI): A new tool for the detection of patients with low risk for major bleeding on thrombolytic therapy	21
Resistance to activated protein C and impaired TFPI activity in women with previous hormone-induced venous thromboembolism	21
D-dimer and risk of venous thromboembolism recurrence: Comparison of two studies with similar designs but different laboratory and clinical results	21
Comparison of absolute immature platelet count to the PLASMIC score at presentation in predicting ADAMTS13 deficiency in suspected thrombotic thrombocytopenic purpura	20
The role of platelets in heat-related illness and heat-induced coagulopathy	20
Identification of phenotypes and predictors for dyspnea, echocardiographic probability of pulmonary hypertension, and confirmed CTEPH in patients with acute pulmonary embolism: Analysis of two large p	20
Association between neutrophil extracellular traps (NETs) and thrombosis in antiphospholipid syndrome	20
Control of warfarin treatment in patients with antiphospholipid syndrome and falsely high INR at point-of-care-testing	20
Prosthetic valve dysfunction in patients with mechanical heart valves: Results from the Emergency Salam Centre cohort	19
Letter to the editor regarding the article “Platelet activity, coagulation, and fibrinolysis in long-term users of anabolic-androgenic steroids compared to strength-trained athletes”	19
Corrigendum to “Rivaroxaban or apixaban in fragile patients with acute venous thromboembolism” [Thromb. Res. 193 (2020) 160–165]	19
Canadian Perspective on Superficial Vein Thrombosis in Pregnancy and Postpartum: Interim Results from a Tertiary Care Centre	19
Editorial Board	19
Venous thromboembolism in hematopoietic stem cell transplantation: A narrative review	18
Optimal enoxaparin dosing strategies for venous thromboembolism prophylaxis and treatment of high body weight patients	18
Myocardial ischemia-reperfusion injury released cellular fibronectin containing domain A (CFN-EDA): A destructive positive loop amplifying arterial thrombosis formation and exacerbating myocardial rep	18
Isolated subsegmental pulmonary embolism identification based on international classification of diseases (ICD)-10 codes and imaging reports	18
Does thromboelastography predict bleeding in patients treated with clopidogrel or ticagrelor in off-pump coronary artery bypass grafting?	18
Statin use and mortality in patients with deep vein thrombosis. Data from the RIETE Registry	18
A survey on clinical practice in monitoring and management of bleeding in children with haemophilia A on emicizumab prophylaxis in the PedNet centres	18
Influence of sex on development of thrombosis in patients with COVID-19: From the CLOT-COVID study	18
Performance of the Bova score in predicting short-term all-cause mortality in patients with pulmonary embolism and normal blood pressure. A systematic review and meta-analysis	18
Platelets activated by different agonists produce microparticles with the same procoagulant properties	18
Real-time risk stratification in acute pulmonary embolism: the utility of RV/LV diameter ratio	18
To aPTT or not to aPTT: Evaluating the optimal monitoring strategy for unfractionated heparin	18
CT coronary calcium score is a prognostic marker in acute pulmonary embolism	18
Thromboelastography as a predictor of functional outcome in acute ischemic stroke patients undergoing endovascular treatment	17
Don't let D-dimer fool you: Elevated D-dimer plasma levels should not imply ‘hyperfibrinolysis’	17
Procoagulant phenotype induced by oxidized high-density lipoprotein associates with acute kidney injury and death	17
Risk of venous thromboembolism in women with endometriosis	17
Sex disparities of clinical manifestations in acute pulmonary embolism and predictive value for in-hospital mortality: Insights from CURES	17
Driver gene KRAS aggravates cancer-associated stroke outcomes	17
Elevated plasma D-dimer levels are associated with risk of future incident venous thromboembolism	17

Clinical and genetic features of Chinese pediatric patients with severe congenital protein C deficiency who first presented with purpura fulminans: A case series study and literature review	17
D-dimer as a predictive biomarker for cancer-associated thrombosis: A prospective cohort study	17
A noncanonical splicing variant c.875-5 T > G in von Willebrand factor causes in-frame exon skipping and type 2A von Willebrand disease	17
Suitability and readiness assessment of organizational resources for the implementation of gene therapy in hemophilia in Spain and Portugal: A survey-based study	16
Editorial Board	16
Optimizing therapeutic enoxaparin in preterm neonates and infants	16
Editorial Board	16
OC-10: Plasmatic von Willebrand factor encapsulates blood circulating melanoma cells to prevent their hematogenous metastasis	16
Abstracts from the CanVECTOR 2024 Annual Conference October 25th, 2024	16
Changes in haemostasis and inflammatory markers after mRNA BNT162b2 and vector Ad26.CoV2.S SARS-CoV-2 vaccination	16
Association between the simplified Pulmonary Embolism Severity Index (sPESI) score and hospitalization in emergency department patients diagnosed with pulmonary embolism	15
SSA-sMLP: A venous thromboembolism risk prediction model using separable self-attention and spatial-shift multilayer perceptrons	15
Barriers and facilitators for adherence to direct oral anticoagulants in patients with atrial fibrillation: A qualitative approach	15
Effect of lupus anti-coagulant and antiphospholipid antibodies on clot waveform analysis parameters	15
Regulation of coagulation activation in newly diagnosed AML by the heme enzyme myeloperoxidase	15
A risk-stratified approach to venous thromboembolism prophylaxis with aspirin or warfarin following total hip and knee arthroplasty: A cohort study	15
Intracoronary antithrombotic therapy during primary percutaneous coronary intervention in patients with STEMI: A systematic review and network meta-analysis	15
The long haul COVID-19 arterial thrombosis	15
Stroke mortality in cancer survivors: A population-based study in Japan	15
Hsa_circ_0001020 accelerates the lower extremity deep vein thrombosis via sponging miR-29c-3p to promote MDM2 expression	14
Atrial fibrillation and peripheral arterial disease define MPN patients with very high risk of thrombosis	14
Rotational thromboelastometry as a biomarker for mortality — The Maastricht Intensive Care COVID cohort	14
Pulmonary embolism diagnostic strategies in patients with COPD exacerbation: Post-hoc analysis of the PEP trial	14
Low-dose immune tolerance induction therapy in severe hemophilia a children in China: Starting earlier resulted in better inhibitor eradication outcomes	14
Hypothermia causes platelet activation in the human spleen	14
Anticoagulation plus antiplatelet therapy versus anticoagulation alone following iliac vein stent implantation in acute and subacute deep vein thrombosis: A multicenter study with propensity score mat	14
Thrombin generation assay in venous thromboembolism: A scoping review	14
Evaluation of modified pediatric sepsis-induced coagulopathy score in pediatric septic shock	14
Thrombocytopenia is associated with a dysregulated host response in severe COVID-19	13
Mental, emotional and social dimensions of quality of life and their relationship with physical and functional status in adults with haemophilia	13
PO-37: A study of the evolution of radiological features of untreated small volume pulmonary embolism (PE) in cancer patients	13
Covid-19 vaccination, adverse events, and detection of antibodies	13
A Predictive Model to Identify Pulmonary Embolism in Unselected Emergency Department Patients: Model Validation and Improvement During the COVID Era	13
Clinical and economic burden of immune tolerance induction in entire patients with hemophilia A: Insights from a real-world Korean setting	13
PO-30: Chemotherapeutic agents temozolomide and lomustine induce procoagulant activity of glioblastoma cell lines in vitro	13
DOACs plasma levels in relation to clinical outcome. How far have we come?	13
PO-54: Preliminary evaluation of venous thromboembolic risk in patients with colorectal cancer from the CARTAGO study	13
Postoperative myocardial injury and platelet reactivity in patients undergoing vascular surgery: The platelet reactivity and postoperative myocardial injury after major vascular surgery (PROMISE) stud	13
Accuracy of physical examination in detecting central venous catheter-associated thrombosis in critically ill children	13
Editorial Board	13
PO-23: Upper extremity deep vein thrombosis in cancer patients: our experience	13
Contact activated kallikrein generation is reduced six months after gastric bypass	13
18F-Fluorodeoxyglucose positron emission/computed tomography for occult cancer among patients with unprovoked venous thromboembolism: What do we know?	13
Letter: In response to a recent letter by Prior et al.	13
Elevated plasma levels of factor VIII enhance arterial thrombus formation on erosive smooth muscle cell-rich neointima but not normal intima in rabbits	12
Long-term recurrence, bleeding, and mortality after first-time subsegmental pulmonary embolism compared to more proximal pulmonary embolism: Findings from the TROLL registry	12
Critique and advice of a multicenter mechanical thrombectomy registry in intermediate-risk PE	12
ROS-driven structural and functional fibrinogen modifications are reverted by interleukin-6 inhibition in Giant Cell Arteritis	12
PO-29: Coagulation and circulating tumour cells as pharmacodynamic biomarkers of response to aromatase inhibitors in breast cancer	12
Acquired von Willebrand syndrome secondary to lymphoproliferative disorders: A case series from two French centers	12
Performance of age-adjusted and fixed threshold D-dimer to exclude DVT in those with low pre-test probability – Single centre experience	12
Protein disulfide isomerase 1 (PDIA1) regulates platelet-derived extracellular vesicle release	12
Safety and efficacy of apixaban as thromboprophylaxis in myeloma patients receiving chemotherapy: A prospective cohort study	12
PO-63: Edoxaban effect in a breast cancer patient with liver arterial infusion chemotherapy (LAIC) and both jugular vein and hepatic artery thrombosis: a unique clinical case	12
Reference values of coagulation assays performed for thrombophilia screening after a first venous thrombosis and their intra-patient associations	12
Incidence and impact of venous thromboembolism in hospitalized patients with Crohn's disease	12
Risk factors for hospital acquired venous thromboembolism in congenital heart disease patients: A report from the children's hospital acquired thrombosis (CHAT) consortium	12
The Attend-PE model: A feasibility study of a structured follow-up care model for patients with pulmonary embolism.	12
PO-47: Prevention and treatment of recurrent trombosis after reconstruction of major vessels	12
Thymidine phosphorylase mediates SARS-CoV-2 spike protein enhanced thrombosis in K18-hACE2TG mice	11
Risks of bleeding and thromboembolic events in patients undergoing colonoscopy on uninterrupted and interrupted anticoagulant therapy in real-world setting	11
Editorial Board	11
Challenging anticoagulation cases: A case of heparin-induced-thrombocytopenia in the first trimester of pregnancy	11
Association between coagulation activity and clinical and imaging outcomes in acute ischemic stroke patients - A sub-study of the MR CLEAN NO-IV trial	11
A systematic review and meta-analysis of periprocedural bridging for patients with mechanical heart valves undergoing non-cardiac interventions	11
Trends of hospital admissions due to acute limb ischemia and venous thromboembolism in Austria: A population-wide observational analysis from 2009 to 2023	11
DOAC Score for prediction of major bleeding in patients with venous thromboembolism: Findings from the RIETE registry	11
Air pollution impacts on in-hospital case-fatality rate of ischemic stroke patients	11
PO-57: Venous thromboembolism recurrence during anticoagulant treatment in gastrointestinal cancer patients	11
Identification of two de novo variants causing inherited antithrombin deficiency by quantitative analysis of variant alleles	11
The contact system in chronic kidney disease and hemodialysis – A cross-sectional study	11
Venous thromboembolism in women with hormone-dependent breast cancer. To continue or discontinue hormonal treatment? Insights from the RIETE registry	11
Increased contact system activity three months after starting combined oral contraceptives	11
Prevention of post-thrombotic syndrome with rosuvastatin: A multicenter randomized controlled pilot trial (SAVER)	11
Outcomes of IVF treatments in women with antiphospholipid antibodies or antiphospholipid syndrome	11
Treating the mind and body: implementation of a psychosocial wellbeing assessment in the deep vein thrombosis clinic	11
Editorial Board	11
Performance of the 4-Level Pulmonary Embolism Clinical Probability Score (4PEPS) in the diagnostic management of pulmonary embolism: An external validation study	11
Enoxaparin for outpatients with COVID-19: 90-day results from the randomised, open-label, parallel-group, multinational, phase III OVID trial	11
Hemostatic considerations for gender affirming care	11

Platelets provide robustness of spatial blood coagulation to the variation of initial conditions	11
Tissue factor expression in monocyte subsets during human immunothrombosis, endotoxemia and sepsis	10
Erythrocyte rheology is altered in haemophilia patients with advanced arthropathy. A case-control study	10
Shiga toxin down-regulates ERG protein in endothelial cells and impairs angiogenesis	10
Low recurrent thrombosis rates in single positive antiphospholipid syndrome regardless of type of anticoagulation	10
Natural history of untreated acute pulmonary embolism in patients with cancer: A retrospective cohort of missed pulmonary emboli	10
The course of pulmonary embolism in individuals recovered from COVID-19	10
Major cardiovascular events after COVID-19, event rates post-vaccination, antiviral or anti-inflammatory therapy, and temporal trends: Correspondence	10
Sustained inflammation, coagulation activation and elevated endothelin-1 levels without macrovascular dysfunction at 3 months after COVID-19	10
Editorial Board	10
Characterization of a prothrombotic phenotype using thrombin generation and thrombin activity in cirrhosis and portal hypertension	10
Association of antithrombotic medications and composition of thrombi retrieved by mechanical thrombectomy in acute ischemic stroke	10
Differential regulation of human thrombospondin-1 upon systemic desmopressin versus endotoxin challenge	10
Evaluation of definitions for oral anticoagulant-associated major bleeding: A population-based cohort study	10
Dynamics of troponins and 30-day mortality in hospitalized patients with pulmonary embolism	10
Newly developed modified diluted prothrombin time reagent: A multi-centre validation in patients with non-valvular atrial fibrillation under direct oral anticoagulant therapy	10
Identification of hematuria with a natural language processing model and validation of hematuria diagnosecodes	10
Machine learning prediction of venous thromboembolism after surgeries of major sellar region tumors	10
Understanding European patterns of deprescribing antithrombotic medication during end-of-life care in patients with cancer	10
Perinatal stroke and hypofibrinogenemia: Is the new missense fibrinogen variant γ p.Gly310Glu the cause of the procoagulant state?	10
Can edoxaban be used at extremes of bodyweight and in patients with a creatinine clearance ≥95 ml/min? – A population pharmacokinetic analysis	10
COVID-19 associated Venous Thromboembolism (VTE) burden in Black women: Findings of Veterans Affairs COVID-19 Shared Data	10
PO-11: Risk of major bleeding in cancer patients with ischemic stroke treated with thrombolysis	10
PO-04: Thrombin generation and D-dimer significantly predict for early disease progression and mortality in patients with gastrointestinal cancer	10
Mitochondrial DNA copy number and its association with venous thromboembolism in patients with cancer	10
Characteristics and outcome of a territory-wide cohort study of patients with acquired hemophilia A in Hong Kong	10
Every 6 seconds in Europe	10
Neutrophil extracellular traps formation may be involved in the association of propranolol with the development of portal vein thrombosis	9
Long-term clinical outcomes in older patients with acute venous thromboembolism who have renal impairment	9
Long-term VTE treatment with rivaroxaban: Results from the DRESDEN NOAC REGISTRY	9
Efficacy and safety of antithrombin or recombinant human thrombomodulin in the treatment of disseminated intravascular coagulation: A systematic review and meta-analysis	9
Incidence and risk factors of post-thrombotic syndrome in patients with isolated calf vein thrombosis. Findings from the GARFIELD-VTE registry	9
Copyright	9
Management strategies and clinical outcomes of venous thromboembolism in patients with antiphospholipid syndrome in the direct oral anticoagulant era: Insight from the COMMAND VTE Registry-2	9
Added IMPACT: The first successful natural birth using certolizumab in obstetric APS	9
Who are we bridging? Description of warfarin patients receiving injectable bridging therapy	9
CXCL13/CXCR5 axis facilitates TFH expansion and correlates with disease severity in adults with immune thrombocytopenia	9
Efficacy and safety of recombinant human soluble thrombomodulin in patients with sepsis-induced disseminated intravascular coagulation - A meta-analysis	9
DOAC drug levels: Does “knowing” lead to safer care?	9
Prognosis after cerebral venous thrombosis: Mortality during initial admission and at 30 days and one year after discharge in a large Canadian population-based cohort	9
Prognostic value of an automated thrombin generation assay in COVID-19 patients entering hospital: A multicentric, prospective observational study	9
Prognostic role of serial electrocardiographic changes in patients with acute pulmonary embolism. Data from the Italian Pulmonary Embolism Registry	9
Adjusted global antiphospholipid syndrome score (aGAPSS) is useful to predict relapses in patients with retinal vein occlusion	9
Molecular basis of clot retraction and its role in wound healing	9
Editorial Board	9
Depression and anxiety up to two years after acute pulmonary embolism: Prevalence and predictors	8
Dielectric blood coagulometry to evaluate coagulation activity in patients prescribed factor Xa inhibitors undergoing elective surgery: A prospective observational study	8
Clinical and endoscopic findings in patients with acute gastrointestinal bleeding associated with direct oral anticoagulants: Results from a single-center prospective cohort study	8
Effectiveness and safety of anticoagulants among venous thromboembolism cancer patients with and without brain cancer	8
Impact of direct oral anticoagulants on evolution of post-thrombotic syndrome	8
Reduction of venous thromboembolic events in COVID-19 patients: Which role for IL-6 antagonists?	8
COVID-19 venous thromboembolism prophylaxis guidelines in pediatrics	8
Editorial Board	8
Defibrotide mitigates endothelial cell injury induced by plasmas from patients with COVID-19 and related vasculopathies	8
The efficacy and safety of andexanet alfa in the treatment of anticoagulation-related major bleedings: An Italian perspective	8
Association between genetic mutations and risk of venous thromboembolism in patients with solid tumor malignancies: A systematic review and meta-analysis	8
Osimertinib-related venous thromboembolism in non small lung cancer	8
In-hospital outcomes of Ticagrelor versus Clopidogrel in high bleeding risk patients with acute coronary syndrome: Findings from the CCC-ACS project	8
Editorial Board	8
Patients with multiple myeloma and monoclonal gammopathy of undetermined significance have variably increased thrombin generation and different sensitivity to the anticoagulant effect of activated pro	8
Management options for pediatric venous thromboembolic disease: Beyond anticoagulation with endovascular therapies	8
Tigecycline-associated hypofibrinogenemia: A single center, retrospective, controlled study	8
Effect of regular exercise training on platelet function in patients with cardiovascular disease and healthy individuals: A systematic review	8
Development and validation of a clinical prediction model for post thrombotic syndrome following anticoagulant therapy for acute deep venous thrombosis	8
Scoping review of current evidence on the incidence of Venous thromboembolism (VTE) in the East Asian population	8
Health-related quality of life associated with warfarin and direct oral anticoagulants in venous thromboembolism	8
Early immune tolerance induction is a unique predictor of favorable outcomes in hemophilia A children with intron 22 inversion and high-responding inhibitors	8
Exploration of rotational thromboelastometry (ROTEM) to characterize the coagulation profiles of newly diagnosed pediatric leukemia patients	8
Outcomes of isolated distal thrombosis managed with serial compression ultrasonography	8
To clot, or not to clot: The dilemma of hormone treatment options for menopause	8
The heat shock protein DNAJB2 as a novel biomarker for essential thrombocythemia diagnosis associated with immune infiltration	7
Treatment patterns and outcomes of second-line rituximab and thrombopoietin receptor agonists in adult immune thrombocytopenia: A Canadian retrospective cohort study	7
20-HETE induced platelet activation via a GPR75-independent pathway	7
Prevalence of antiphospholipid antibody syndrome misclassification in an academic health system	7
Blood group non-O is not associated with long-term adverse outcomes in patients undergoing percutaneous coronary intervention	7
Panel of genetic risk markers for prediction of susceptibility towards venous thromboembolism (VTE)	7
Venous thrombotic events in patients treated with immune checkpoint inhibitors for non-small cell lung cancer: A retrospective multicentric cohort study	7
Hemostatic alterations in metabolic dysfunction-associated steatotic liver disease (MASLD) and their link to venous thromboembolism (VTE)	7
Editorial Board	7
Oral anticoagulants and cognitive impairment in patients with atrial fibrillation: A systematic review with meta-analysis and trial sequential analysis	7
A RIETE registry analysis of patients with upper extremity deep vein thrombosis and thoracic outlet syndrome	7
Chemotherapy alters thrombomodulin and factor VIIIc expression resulting in acquired activated protein C resistance and enhanced thrombin generation in cancer associated thrombosis	7
Risk of venous and arterial thromboembolic events in women with advanced breast cancer treated with CDK 4/6 inhibitors: A systematic review and meta-analysis	7
Differential prognosis of patients that are candidates for standard, short or prolonged dual antiplatelet treatment discharged after an acute coronary syndrome	7
Role of neutrophil extracellular traps in vascular access thrombosis in hemodialysis patients	7
Influence of primary cancer site on clinical outcomes of anticoagulation for associated venous thromboembolism	7
Epigenetic repression of THBD transcription by BRG1 contributes to deep vein thrombosis	7
Risk of thromboembolism according to statin treatment in patients with cancer: A nationwide nested case-control study	7
D-dimer to fibrinogen ratio predicts early neurological deterioration in ischemic stroke with atrial fibrillation	7
Clinical prediction tool to identify children at risk of pulmonary embolism	7
Apixaban thromboprophylaxis in ambulatory patients with cancer and obesity: Insights from the AVERT trial	7
Prognostic significance of saddle pulmonary embolism a post hoc analysis of the PROTECT cohort study	7
The effect of COVID-19 vaccination on anticoagulation stability in adolescents and young adults using vitamin K antagonists	7
Prothrombotic plasma fibrin clot phenotype is associated with spontaneous echo contrast in atrial fibrillation: The role of protein carbonylation	7
Phenotype, genotype, and laboratory assessment of congenital fibrinogen disorders: Data from the Rare Bleeding disorders in the Netherlands study	7